Aortic valve replacement in a patient with sickle cell disease—Are we justified to perform surgery in the TAVI era?

Abstract Not all variants of SCD need the same management and this should be decided on a case‐by‐case basis. Heterozygous SCD patients can undergo cardiac surgery without the need for intraoperative exchange transfusions with good clinical outcomes.